249 related articles for article (PubMed ID: 26774927)
1. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
[TBL] [Abstract][Full Text] [Related]
2. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
Palermo G; Favia AD; Convertino M; De Vivo M
ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
Favia AD; Habrant D; Scarpelli R; Migliore M; Albani C; Bertozzi SM; Dionisi M; Tarozzo G; Piomelli D; Cavalli A; De Vivo M
J Med Chem; 2012 Oct; 55(20):8807-26. PubMed ID: 23043222
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
7. A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.
Scarpelli R; Sasso O; Piomelli D
ChemMedChem; 2016 Jun; 11(12):1242-51. PubMed ID: 26486424
[TBL] [Abstract][Full Text] [Related]
8. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
[TBL] [Abstract][Full Text] [Related]
9. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
[TBL] [Abstract][Full Text] [Related]
10. A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.
Bertolacci L; Romeo E; Veronesi M; Magotti P; Albani C; Dionisi M; Lambruschini C; Scarpelli R; Cavalli A; De Vivo M; Piomelli D; Garau G
J Am Chem Soc; 2013 Jan; 135(1):22-5. PubMed ID: 23240907
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and
Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
[TBL] [Abstract][Full Text] [Related]
12. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
[TBL] [Abstract][Full Text] [Related]
13. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
15. Atropisomerism observed in indometacin derivatives.
Takahashi H; Wakamatsu S; Tabata H; Oshitari T; Harada A; Inoue K; Natsugari H
Org Lett; 2011 Feb; 13(4):760-3. PubMed ID: 21250752
[TBL] [Abstract][Full Text] [Related]
16. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
Shaveta ; Singh A; Kaur M; Sharma S; Bhatti R; Singh P
Eur J Med Chem; 2014 Apr; 77():185-92. PubMed ID: 24631898
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
[TBL] [Abstract][Full Text] [Related]
19. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
Deplano A; Karlsson J; Fowler CJ; Onnis V
Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]